Deep Chakrabarti

Consultant Uro-Oncology @TheChristieNHS, formerly @royalmarsdenNHS and @kgmu_medical, Keen on Football/Ethics/Aviation/Cats

[Chris Parker @PCaParker]

@TylerSbrt @jryckman3 @cpeedell @urotoday @zklaassen_md @DanaFarber @TDorffOnc @cityofhope I think we do know when to add an ARPI to radical prostatectomy: Never. No good reason to add drug cost and toxicity when no benefit in OS, QoL or even MFS (by conventional imaging)?

[Nicholas Zaorsky, MD MS @NicholasZaorsky]

My @ASTRO_org 2026 GU spring refresher extended "long-course" slide deck is available at
https://t.co/HND3LmzgZb

You can also watch the "short-course" 1.5 hour narrated version here:
https://t.co/GpDtfapF4K

[Daniel E Spratt @DrSpratticus]

Interesting that partial gland therapies were not even in the trial. Ivermectin may also offer a better alternative.

Perhaps the evidence based conclusion is that active monitoring is the preferred approach based on level 1 data.

[Jenna Taglienti @jenna_taglienti]

I wrote this in a moment I never would have chosen. A sudden pause that made me see my life clearly.

The meaning of our work is profound. This experience simply helped me see more clearly what matters most.

“Time is Finite” JAMA

https://t.co/IwkKdyeEWx

[Chris Parker @PCaParker]

@ethansgrumps @AdamSharpMedOnc Thanks. If I was the patient, I would prefer the STAMPEDE-2 trial, which mandates prostate radiotherapy, and tests the addition of SBRT to the oligomets.

[Zach Klaassen @zklaassen_md]

#EAU26 long-term results from randomized ARTO Ph II trial (SBRT + AA vs AA):

• bPFS: 43 vs 17 mo (HR 0.49, p<0.001)
• rPFS: 44 vs 17 mo (HR 0.48, p<0.001)
• OS: NR vs 50 mo (HR 0.55, p=0.02)
• PCSS: NR vs NR (HR 0.37, p=0.006)

Supports Ph 3 trials of met-directed SBRT + systemic Rx in oligomet CRPC @urotoday

[Deep Chakrabarti @DeepOnco]

@drkeithsiau Where is Edoxaban?

[Keith Siau @drkeithsiau]

😅

[Yüksel Ürün @DrYukselUrun]

I would stand up, but I need to sit here to finish reading about how sitting is increasing mortality risk.

[Prof Ananya💙 @achoud72.bsky.social @achoud72]

#GU26 - first visit since COVID. Already bumped into old friends as if I've never been away.
Highlighting a piece by @Hannah_Brom describing why we need to do the #ENHANCE trial - high v low dose ARPI @ProstateUKProfs @CRUKresearch @MCRCnews @ManchesterBRC
https://t.co/aa0tQ40OSW

[CA: A Cancer Journal for Clinicians @CACancerJournal]

This 2025 review article, led by @DeepOnco of @royalmarsdenNHS, outlines global trends and the evolving diagnostics, treatment, and surveillance of #ProstateCancer: https://t.co/AUAGW1mzrM

@PCaParker @AmarUKishan @VedangMurthy @nickva1 @alison_tree @APCCC_Lugano @ICR_London

[Deep Chakrabarti @DeepOnco]

Delighted to join @TheChristieNHS today as a Consultant Clinical Oncologist focused on urological cancers. Little by little, one travels far !

[Deep Chakrabarti @DeepOnco]

@Rishabh2970 @aiims_newdelhi Sad but not surprising, and quite sure other top institutes do it all the time too. The bias also percolates to faculty recruitment. Unfortunately, any “subjective” assessment will benefit internal/favoured candidates.

[Deep Chakrabarti @DeepOnco]

Just out in @LearnedPublish @alpsp our guide for publishers to collab with #ECRs for a more equitable and rigorous #ScholarlyPublishing system. Developed following a Jan 2023 unconference by @ChariteBerlin

@WileyGlobal #OpenResearch

Full text link:
https://t.co/A1ITgLf44h

[Peter Brennan @BrennanSurgeon]

On this day in 1895, the first X ray was taken

130 years later, radiology has advanced exponentially

Who knows where medical imaging will be in another 130 years?

Thank you to often unseen colleagues who do an amazing job for our patients

Happy International Radiology Day

[Chris Parker @PCaParker]

This lucid editorial on prostate cancer screening is worth reading.
Early Detection of Prostate Cancer — Time to Fish or Cut Bait | New England Journal of Medicine https://t.co/MFECsbwJ1b

[Mark Lewis, MD, FASCO @marklewismd]

Incredible essay 👇🏻

I fear becoming insensate more than I fear serial loss

The day we don’t feel is the day we need to recalibrate whether compassion fatigue has exhausted our ability to experience the human side of medicine

The highs &amp; lows shouldn’t sum to numb neutrality

[Mark Lewis, MD, FASCO @marklewismd]

What happens in vagus doesn’t stay in vagus

[Deep Chakrabarti @DeepOnco]

Huge congratulations @LauraMarandino 🙌

[ESMO - Eur. Oncology @myESMO]

👏We are pleased to announce @LauraMarandino as the 2025 recipient of the ESMO José Baselga Fellowship for Clinician Scientists. This fellowship, supported by AZ, provides the resources &amp; #mentorship for #ClinicianScientists. #ESMO25
@TheCrick @royalmarsdenNHS

[Deep Chakrabarti @DeepOnco]

Loved this in the Autumn Wave magazine ! @RCRadiologists #ClinicalOncology #Neurodiversity